PharmaShots | Incisive News in 3 Shots

Subscribe Now

Recommend

EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars

EMA's CHMP Recommends the Approval of Two Bevacizumab Biosimilars

January 28, 2021

EMA's CHMP Recommends the Approval of Two Biosimilar Referencing Lilly's Forsteo (teriparatide) for the Treatment of Osteoporosis

EMA's CHMP Recommends the Approval of Two Biosimilar Referencing Lilly's Forsteo (teriparatide) for the Treatment of Osteoporosis

June 26, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us